Panel Discussion

Time: 5:00 pm
day: Day Two


With an increase in investment and development of mRNA technology platforms and upcoming biotechs this calls for further clarity to standardise frameworks for future innovations. It is critical within the mRNA space to streamline practices for mRNA- based therapeutics across the development value chain and overcome key bottlenecks for better clinical translation.

  • How to accelerate platforms for future innovative technologies, applications and commercial opportunities?
  • How to standardise mRNA technology platforms and its potential applications?
  • How to identify and successfully address the key bottlenecks from early discovery to clinical translation for mRNA- based therapeutics?